111 related articles for article (PubMed ID: 7687445)
1. Interferon for subfoveal choroidal neovascularisation.
Groeneveld E; Eliadis P
Aust N Z J Ophthalmol; 1993 May; 21(2):133-4. PubMed ID: 7687445
[No Abstract] [Full Text] [Related]
2. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
Thomas MA; Ibanez HE
Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
[TBL] [Abstract][Full Text] [Related]
3. Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.
Loughnan MS; Heriot WJ; O'Day J
Aust N Z J Ophthalmol; 1992 Aug; 20(3):173-5. PubMed ID: 1280447
[TBL] [Abstract][Full Text] [Related]
4. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
Engler C; Sander B; Villumsen J; Lund-Andersen H
Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Britton WA; Leonard BC
Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
[No Abstract] [Full Text] [Related]
6. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
7. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
8. The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study.
Chan CK; Kempin SJ; Noble SK; Palmer GA
Ophthalmology; 1994 Feb; 101(2):289-300. PubMed ID: 7509472
[TBL] [Abstract][Full Text] [Related]
9. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
11. We are very spoiled.
Fine SL; Maguire MG
Arch Ophthalmol; 1997 Jul; 115(7):915-6. PubMed ID: 9230835
[No Abstract] [Full Text] [Related]
12. Idiopathic subfoveal choroidal neovascularization.
Lempert P
Ophthalmology; 1995 Oct; 102(10):1411-2. PubMed ID: 9097781
[No Abstract] [Full Text] [Related]
13. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
14. Laser photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Hawkins WR
Arch Ophthalmol; 1995 May; 113(5):554. PubMed ID: 7538291
[No Abstract] [Full Text] [Related]
15. Systemic interferon-alpha 2a and subretinal neovascular membranes.
Constable I
Aust N Z J Ophthalmol; 1992 Aug; 20(3):155. PubMed ID: 1280446
[No Abstract] [Full Text] [Related]
16. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
17. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans.
de Juan E; Loewenstein A; Bressler NM; Alexander J
Am J Ophthalmol; 1998 May; 125(5):635-46. PubMed ID: 9625547
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial.
Lewis H; VanderBrug Medendorp S
Ophthalmology; 1997 Nov; 104(11):1847-51; discussion 1852. PubMed ID: 9373115
[TBL] [Abstract][Full Text] [Related]
19. Surgical removal of subfoveal neovascularization.
Russell SR; Crapotta JA; Zerbolio DJ
Ophthalmology; 1993 Jun; 100(6):795-7. PubMed ID: 7685512
[No Abstract] [Full Text] [Related]
20. Tissue plasminogen activator in the surgical excision of subfoveal choroidal neovascular membranes.
Thomas JW; Lopez PF; Lambert HM
Ophthalmic Surg; 1995; 26(4):374-6. PubMed ID: 8532296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
